UNI-EN 31:Notifications for disclosure of share participation 31 190315
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 31 | / | 2015 | | ||||||
| Date of issue: | 2015-03-19 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notifications for disclosure of share participation 31 190315 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 70 pkt 1 Ustawy o ofercie - nabycie lub zbycie znacznego pakietu akcji | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") announces that on 19 March 2015 the Company received Notifications for disclosure of share participation under art. 145 of POSA from Donev Investments Holding AD, Telecomplect Invest AD and Telso AD for change in their share participation in Sopharma AD due to the capital increase of Sopharma AD through the merger of Bulgarian Rose Sevtopolis AD. - Donev Investments Holding AD – the share participation in Sopharma AD decreases from 25.26% to 24.74%; - Telecomplect Invest AD – the share participation in Sopharma AD decreases from 20.41% to 19.99%; - Telso AD – the share participation in Sopharma AD increases from 4.98% to 5.29%; The date of registration of the transaction in the Central Depository AD is 6 March 2015. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Notifications for disclosure of share participation 31 190315.doc Notifications for disclosure of share participation 31 190315.doc | Notifications for disclosure of share participation 31 190315 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2015-03-19 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.75 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
